1887

Abstract

A cellular receptor for the haemagglutinating enteroviruses (HEV), and the protein that mediates haemagglutination, is the membrane complement regulatory protein decay accelerating factor (DAF; CD55). Although primate DAF is highly conserved, significant differences exist to enable cell lines derived from primates to be utilized for the characterization of the DAF binding phenotype of human enteroviruses. Thus, several distinct DAF-binding phenotypes of a selection of HEVs (viz. coxsackievirus A21 and echoviruses 6, 7, 11–13, 29) were identified from binding and infection assays using a panel of primate cells derived from human, orang-utan, African Green monkey and baboon tissues. These studies complement our recent determination of the crystal structure of SCR of human DAF [ Williams, P., Chaudhry, Y., Goodfellow, I. G., Billington, J., Powell, R., Spiller, O. B., Evans, D. J. & Lea, S. (2003). , 10691–10696 ] and have enabled us to better map the regions of DAF with which enteroviruses interact and, in certain cases, predict specific virus–receptor contacts.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19674-0
2004-03-01
2019-11-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/3/vir850731.html?itemId=/content/journal/jgv/10.1099/vir.0.19674-0&mimeType=html&fmt=ahah

References

  1. Bergelson, J. M., Chan, M., Solomon, K. R., St John, N. F., Lin, H. & Finberg, R. W. ( 1994; ). Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci U S A 91, 6245–6249.[CrossRef]
    [Google Scholar]
  2. Brodbeck, W. G., Liu, D., Sperry, J., Mold, C. & Medof, M. E. ( 1996; ). Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. J Immunol 156, 2528–2533.
    [Google Scholar]
  3. Clarkson, N. A., Kaufman, R., Lublin, D. M., Ward, T., Pipkin, P. A., Minor, P. D., Evans, D. J. & Almond, J. W. ( 1995; ). Characterization of the echovirus-7 receptor – domains of CD55 critical for virus binding. J Virol 69, 5497–5501.
    [Google Scholar]
  4. Coyne, K. E., Hall, S. E., Thompson, E. S., Acre, M. A., Kinoshita, T., Fujita, T., Anstee, D. J., Rosse, W. & Lublin, D. M. ( 1992; ). Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol 149, 2906–2913.
    [Google Scholar]
  5. Goodfellow, I., Khojine, A., Powell, R. & Evans, D. ( 2001; ). Echoviruses bind heparan sulphate at the cell surface. J Virol 75, 4918–4912.[CrossRef]
    [Google Scholar]
  6. Hall, T. A. ( 1999; ). BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41, 95–98.
    [Google Scholar]
  7. Hamann, J., Vogel, B., van Schijndel, G. M. & van Lier, R. A. ( 1996; ). The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 184, 1185–1189.[CrossRef]
    [Google Scholar]
  8. Hamann, J., Stortelers, C., Kiss Toth, E., Vogel, B., Eichler, W. & van Lier, R. A. ( 1998; ). Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Eur J Immunol 28, 1701–1707.[CrossRef]
    [Google Scholar]
  9. Hasan, R. J., Pawelczyk, E., Urvil, P. T. & 7 other authors ( 2002; ). Structure–function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation. Infect Immun 70, 4485–4493.[CrossRef]
    [Google Scholar]
  10. He, Y., Lin, F., Chipman, P. R., Bator, C. M., Baker, T. S., Shoham, M., Kuhn, R. J., Medof, M. E. & Rossmann, M. G. ( 2002; ). Structure of decay-accelerating factor bound to echovirus 7: a virus–receptor complex. Proc Natl Acad Sci U S A 99, 10325–10329.[CrossRef]
    [Google Scholar]
  11. Karnauchow, T. M., Tolson, D. L., Harrison, B. A., Altman, E., Lublin, D. M. & Dimock, K. ( 1996; ). The HeLa cell receptor for enterovirus 70 is decay accelerating factor (CD55). J Virol 70, 5143–5152.
    [Google Scholar]
  12. Karnauchow, T. M., Dawe, S., Lublin, D. M. & Dimock, K. ( 1998; ). Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding. J Virol 72, 9380–9383.
    [Google Scholar]
  13. Kuttner-Kondo, L., Bala Subramanian, V., Atkinson, J. P., Yu, J. & Medof, M. E. ( 2000; ). Conservation in decay accelerating factor (DAF) structure among primates. Dev Comp Immunol 24, 815–827.[CrossRef]
    [Google Scholar]
  14. Lea, S., Powell, R., McKee, T., Evans, D., Brown, D., Stuart, D. & van der Merwe, P. ( 1998; ). Determination of the affinity and kinetic constants for the interaction between the human echovirus 11 and its cellular receptor CD55. J Biol Chem 273, 30443–30447.[CrossRef]
    [Google Scholar]
  15. Lublin, D. M. & Atkinson, J. P. ( 1989; ). Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol 7, 35–58.[CrossRef]
    [Google Scholar]
  16. Nickells, M. W., Alvarez, J. I., Lublin, D. M. & Atkinson, J. P. ( 1994; ). Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1. J Immunol 152, 676–685.
    [Google Scholar]
  17. Patel, J. R., Daniel, J. & Mathan, V. I. ( 1985; ). An epidemic of acute diarrhoea in rural southern India associated with echovirus type 11 infection. J Hyg (Lond) 95, 483–492.[CrossRef]
    [Google Scholar]
  18. Powell, R. M., Ward, T., Evans, D. J. & Almond, J. W. ( 1997; ). Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation. J Virol 71, 9306–9312.
    [Google Scholar]
  19. Powell, R. M., Schmidtt, V., Ward, T., Goodfellow, I., Evans, D. J. & Almond, J. W. ( 1998; ). Characterization of echoviruses that bind decay accelerating factor (CD55); evidence that some haemagglutinating strains use more than one cellular receptor. J Gen Virol 79, 1707–1713.
    [Google Scholar]
  20. Powell, R. M., Ward, T., Goodfellow, I. G., Almond, J. W. & Evans, D. J. ( 1999; ). Mapping the binding domains on decay accelerating factor for haemagglutinating enteroviruses; implications for the evolution of a DAF binding phenotype. J Gen Virol 80, 3145–3152.
    [Google Scholar]
  21. Shafren, D. R., Bates, R. C., Agrez, M. V., Herd, R. L., Burns, G. F. & Barry, R. D. ( 1995; ). Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 69, 3873–3877.
    [Google Scholar]
  22. Shafren, D. R., Dorahy, D. J., Ingham, R. A., Burns, G. F. & Barry, R. D. ( 1997a; ). Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol 71, 4736–4743.
    [Google Scholar]
  23. Shafren, D. R., Williams, D. T. & Barry, R. D. ( 1997b; ). A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J Virol 71, 9844–9848.
    [Google Scholar]
  24. Shafren, D. R., Dorahy, D. J., Thorne, R. F., Kinoshita, T., Barry, R. D. & Burns, G. F. ( 1998; ). Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity. J Immunol 160, 2318–2323.
    [Google Scholar]
  25. Shieh, J. T. & Bergelson, J. M. ( 2002; ). Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells. J Virol 76, 9474–9480.[CrossRef]
    [Google Scholar]
  26. Spiller, O. B., Goodfellow, I. G., Evans, D. J., Almond, J. W. & Morgan, B. P. ( 2000; ). Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF. J Infect Dis 181, 340–343.[CrossRef]
    [Google Scholar]
  27. Spiller, O. B., Goodfellow, I. G., Evans, D. J., Hinchliffe, S. J. & Morgan, B. P. ( 2002; ). Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF. J Gen Virol 83, 45–52.
    [Google Scholar]
  28. Thompson, J. D., Higgins, D. G. & Gibson, T. J. ( 1994; ). clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673–4680.[CrossRef]
    [Google Scholar]
  29. Uhrinova, S., Lin, F., Ball, G., Bromek, K., Uhrin, D., Medof, M. E. & Barlow, P. N. ( 2003; ). Solution structure of a functionally active fragment of decay-accelerating factor. Proc Natl Acad Sci U S A 100, 4718–4723.[CrossRef]
    [Google Scholar]
  30. Ward, T., Pipkin, P. A., Clarkson, N. A., Stone, D. M., Minor, P. D. & Almond, J. W. ( 1994; ). Decay accelerating factor (CD55) identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J 13, 5070–5074.
    [Google Scholar]
  31. Williams, P., Chaudhry, Y., Goodfellow, I. G., Billington, J., Powell, R., Spiller, O. B., Evans, D. J. & Lea, S. ( 2003; ). Mapping CD55 function : the structure of two pathogen-binding domains at 1·7Å. J Biol Chem 278, 10691–10696.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19674-0
Loading
/content/journal/jgv/10.1099/vir.0.19674-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error